587 related articles for article (PubMed ID: 15834457)
21. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
Carlson BB; Wisniecki A; Salamone JD
Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151
[TBL] [Abstract][Full Text] [Related]
22. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
24. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
25. Modulation of GABA release by dopamine in the substantia nigra.
Matuszewich L; Yamamoto BK
Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
[TBL] [Abstract][Full Text] [Related]
26. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Turner MS; Gray TS; Mickiewicz AL; Napier TC
Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
[TBL] [Abstract][Full Text] [Related]
27. Effects of NMDA administration in the substantia nigra pars compacta on the striatal dopamine release before and after repetitive exposures to nitrogen narcosis in rats.
Lavoute C; Weiss M; Rostain JC
Undersea Hyperb Med; 2006; 33(3):175-9. PubMed ID: 16869531
[TBL] [Abstract][Full Text] [Related]
28. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
29. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
[TBL] [Abstract][Full Text] [Related]
30. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
31. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
32. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
[TBL] [Abstract][Full Text] [Related]
33. Receptor subtype-specific dopaminergic agents and unconditioned behavior.
Beninger RJ; Mazurski EJ; Hoffman DC
Pol J Pharmacol Pharm; 1991; 43(6):507-28. PubMed ID: 1687945
[TBL] [Abstract][Full Text] [Related]
34. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors.
Ibañez-Sandoval O; Hernández A; Florán B; Galarraga E; Tapia D; Valdiosera R; Erlij D; Aceves J; Bargas J
J Neurophysiol; 2006 Mar; 95(3):1800-11. PubMed ID: 16306171
[TBL] [Abstract][Full Text] [Related]
35. GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra.
Cortés H; Paz F; Erlij D; Aceves J; Florán B
Eur J Pharmacol; 2010 Dec; 649(1-3):161-7. PubMed ID: 20863782
[TBL] [Abstract][Full Text] [Related]
36. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
37. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
Ruskin DN; Bergstrom DA; Walters JR
J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
[TBL] [Abstract][Full Text] [Related]
38. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Boldry RC; Chase TN; Engber TM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
[TBL] [Abstract][Full Text] [Related]
39. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
Trugman JM; Arnold WS; Touchet N; Wooten GF
J Pharmacol Exp Ther; 1989 Sep; 250(3):1156-60. PubMed ID: 2674418
[TBL] [Abstract][Full Text] [Related]
40. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
